Related Experiment Videos
Fenugreek bread: a treatment for diabetes mellitus
Jack N Losso1, Darryl L Holliday, John W Finley
1Food Science Department, Louisiana State University Agricultural Center, Baton Rouge, Louisiana, USA.
Journal of Medicinal Food
|October 28, 2009
Summary
Fenugreek bread, despite its bitter reputation, was found to be as acceptable as regular bread. This new bread formulation effectively reduces insulin resistance, offering a potential dietary strategy for managing type 2 diabetes.
Area of Science:
- Nutritional Science
- Food Science
- Metabolic Health
Background:
- Fenugreek is known for its blood sugar-lowering properties but is limited by its taste.
- Developing palatable fenugreek-based foods is crucial for therapeutic use.
- This study addresses the challenge of incorporating fenugreek into a widely consumed food product.
Purpose of the Study:
- To assess the taste acceptability of fenugreek bread.
- To evaluate the impact of fenugreek bread on carbohydrate metabolism in diabetic individuals.
- To determine if fenugreek can be incorporated into bread without negatively affecting sensory qualities.
Main Methods:
- A fenugreek bread formula was developed and produced in a commercial bakery.
- Eight diet-controlled diabetic subjects consumed fenugreek bread and control whole wheat bread in a double-blind, randomized study.
- Blood glucose and insulin levels were monitored over 4 hours post-consumption; sensory attributes were also evaluated.
Main Results:
- Fenugreek bread showed no significant differences in proximate composition, color, firmness, texture, or flavor intensity compared to whole wheat bread.
- While glucose response was not significantly altered, the insulin response area under the curve was significantly lower with fenugreek bread (P < .05).
- The fenugreek bread was sensorially indistinguishable from the control, overcoming typical negative impacts on bread quality.
Conclusions:
- Acceptable baked products containing fenugreek can be produced using a proprietary process.
- Fenugreek-containing bread retains its functional property of reducing insulin resistance.
- This palatable fenugreek bread offers a promising dietary approach for managing type 2 diabetes and improving metabolic health.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...